Gilead is no stranger to sponsoring and conducting trials in Australia.
Whether for commercial reasons or for the scientific prowess/community I have no idea BUT there is NO DOUBT their contact network here is already in place, hospitals included.
So may be AB's and thrasher's joining the dots isn't too far off the mark.
Take a look at the below stats and ponder the possibilites!
"In early phase clinicaltrials Australia is28 per cent cheaperthan the US beforetax incentives, and60 per cent cheaperafter tax incentives."
Quote from: Australia: Preferred Destination forEarly Phase Clinical Trials. Frost &Sullivan White Paper 2016
- Forums
- ASX - By Stock
- SPL
- SPL7013 outperformed Gilead against COVID-19
SPL7013 outperformed Gilead against COVID-19, page-33
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.002(2.11%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.8¢ | 9.8¢ | 9.2¢ | $150.3K | 1.582M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11175 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 404 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11253 | 0.096 |
2 | 265000 | 0.095 |
1 | 227075 | 0.093 |
2 | 68260 | 0.092 |
1 | 50050 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 475 | 2 |
0.098 | 105712 | 4 |
0.099 | 18000 | 1 |
0.100 | 148705 | 4 |
0.105 | 96531 | 4 |
Last trade - 14.35pm 24/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online